Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Avillion LLP
Avillion LLP
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Finance
Avillion appoints Kathryn J. Gregory as Chief Business Officer
Regulatory
US FDA and EMA accept submission of BOSULIF for CML treatment
Applications seek to expand approved use of BOSULIF into first-line treatment based on positive results from Phase 3 head-to-head trial
Pharmaceutical
Nanobodies could lead to a new generation of biological drugs
Avillion signs clinical co-development agreement with Merck to advance Anti IL-17 A/F Nanobody in psoriasis
Finance
Avillion appoints Mark Weinberg as Chief Medical Officer
Mark Weinberg will be based in Chicago as CMO for co-developer and financier of late-stage pharmaceutical product candidates
Research & Development
Jarrod Longcor joins Avillion as Chief Business Officer
Will take responsibility for negotiating co-development agreements and financial investments
Research & Development
Dr Allison Jeynes-Ellis becomes Chief Executive at Avillion
Founding member of management team and formerly Chief Medical Officer at the company
Subscribe now